William C. Gruber

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults”.

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Nature(2020)10.1038/s41586-020-2639-4

N/A

9.3DataRank · unranked

1589 citations

Kirsten E. Lyke, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart +20 more

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

New England Journal of Medicine(2020)10.1056/nejmoa2034577

N/A

1.4DataRank · unranked

15369 citations

Stephen J. Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart +26 more

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

New England Journal of Medicine(2020)10.1056/nejmoa2027906

N/A

1.2DataRank · unranked

2718 citations

Robert W. Frenck, Ann R. Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman +23 more

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

medRxiv(2020)10.1101/2020.08.17.20176651

N/A

0.757DataRank · unranked

155 citations

Robert W. Frenck, Ann R. Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman +20 more

385. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to 5- to 11-Year-Old Children Who Previously Received 3 Doses of Original BNT162b2

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.455

N/A

0.104DataRank · unranked

1 citations

Lawrence Sher, Charu Sabharwal, Nicholas Kitchin, Sungeen Hill, Emily Wasserman +19 more